Clinical Investigative Site 6917 — Boston, Massachusetts

Clinical Investigative Site 6917 is a clinical research site located in Boston, Massachusetts, United States 02111.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Investigative Site 6917 has participated in 1 clinical trials.

Therapeutic areas: Clostridium Difficile Infection.

Sponsors: Actelion.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Investigative Site 6917?

Clinical Investigative Site 6917 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Investigative Site 6917 conducted?

Clinical Investigative Site 6917 has 1 clinical trials on record. Their work covers Clostridium Difficile Infection.

Is Clinical Investigative Site 6917 accredited by Crixeo Health?

Clinical Investigative Site 6917 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Investigative Site 6917?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.